TCT (Transcatheter Cardiovascular Therapeutics) 2007: PFO (patent foramen ovale) closure trial misses "unrealistic" migraine endpoint
This article was originally published in Clinica
Executive Summary
Trials of NMT Medical's STARFlex septal repair implant have had mixed results, suggesting the device may not be as suitable for the treatment of migraine as previously thought. Results from the MIST I trial were presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2007 meeting, held in Washington, DC, by Andrew Dowson, director of headache services at King's College Hospital in London, UK.